Endo/Lysosomal-Escapable Lipid Nanoparticle Platforms for Enhancing mRNA Delivery in Cancer Therapy
Pharmaceutics · 20.06.2025 · 17 (7) · 803
DOI: 10.3390/pharmaceutics17070803 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 20.06.2025. Verfasst von Jiapeng Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Imageology, The Second Clinical College of Guangzhou Medical University, Guangzhou 511436, China. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 139 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangzhou Postdoctoral Strat-up Fund, Postdoctoral Strat-up Fund, Guangdong Province Graduate Education Innovation Plan Project-Graduate Demonstration Course.
Abstract (Originalsprache)
mRNA-based drug development is revolutionizing tumor therapies by enabling precise cancer immunotherapy, tumor suppressor gene restoration, and genome editing. However, the success of mRNA therapies hinges on efficient delivery systems that can protect mRNA from degradation and facilitate its release into the cytoplasm for translation. Despite the emergence of lipid nanoparticles (LNPs) as a clinically advanced platform for mRNA delivery, the efficiency of endo/lysosomal escape still represents a substantial bottleneck. Here, we summarize the intracellular fate of mRNA-loaded LNPs, focusing on their internalization pathways and processing within the endo-lysosomal system. We also discuss the impact of endo-lysosomal processes on mRNA delivery and explore potential strategies to improve mRNA escape from endo-lysosomal compartments. This review focuses on molecular engineering strategies to enhance LNP-mediated endo/lysosomal escape by optimizing lipid composition, including ionizable lipids, helper lipids, cholesterol, and PEGylated lipids. Additionally, ancillary enhancement strategies such as surface coating and shape management are discussed. By comprehensively integrating mechanistic insights into the journey of LNPs within the endo-lysosome system and recent advances in lipid chemistry, this review offers valuable inspiration for advancing mRNA-based cancer therapies by enabling robust protein expression.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Imageology, The Second Clinical College of Guangzhou Medical University, Guangzhou 511436, China.
- State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou 511436, China.
ORCID-Profile: Jiapeng Wang
Förderung
- Guangzhou Postdoctoral Strat-up Fund
- Postdoctoral Strat-up Fund
- Guangdong Province Graduate Education Innovation Plan Project-Graduate Demonstration Course
Zitieren
APA
Wang, J., Chen, R., Xie, Y., Qin, X., Zhou, Y., & Xu, C. (2025). Endo/Lysosomal-Escapable Lipid Nanoparticle Platforms for Enhancing mRNA Delivery in Cancer Therapy. Pharmaceutics, 17(7), 803. https://doi.org/10.3390/pharmaceutics17070803
Vancouver
Wang J, Chen R, Xie Y, Qin X, Zhou Y, Xu C. Endo/Lysosomal-Escapable Lipid Nanoparticle Platforms for Enhancing mRNA Delivery in Cancer Therapy. Pharmaceutics. 2025;17(7):803. doi:10.3390/pharmaceutics17070803
BibTeX
@article{Wang2025,
author = {Wang, Jiapeng and Chen, Renjie and Xie, Yongyi and Qin, Xuanting and Zhou, You and Xu, Chuanshan},
title = {Endo/Lysosomal-Escapable Lipid Nanoparticle Platforms for Enhancing mRNA Delivery in Cancer Therapy},
journal = {Pharmaceutics},
year = {2025},
volume = {17},
number = {7},
pages = {803},
doi = {10.3390/pharmaceutics17070803}
}
EUVIMED